| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.20T | 13.70T | 13.37T | 13.14T | 12.16T | 11.94T |
| Gross Profit | 3.04T | 3.79T | 1.92T | 1.83T | 1.77T | 9.48T |
| EBITDA | 3.64T | 3.51T | 3.74T | 3.41T | 3.33T | 3.20T |
| Net Income | 1.09T | 1.00T | 1.28T | 1.21T | 1.18T | 916.18B |
Balance Sheet | ||||||
| Total Assets | 46.87T | 30.06T | 29.60T | 25.31T | 23.86T | 22.97T |
| Cash, Cash Equivalents and Short-Term Investments | 2.82T | 1.00T | 1.05T | 892.57B | 923.00B | 977.46B |
| Total Debt | 18.24T | 11.17T | 10.71T | 9.15T | 8.21T | 8.37T |
| Total Liabilities | 36.87T | 18.72T | 18.71T | 15.96T | 14.84T | 14.76T |
| Stockholders Equity | 9.52T | 10.22T | 9.84T | 8.56T | 8.28T | 7.56T |
Cash Flow | ||||||
| Free Cash Flow | -54.53B | 231.74B | 290.15B | 409.13B | 1.25T | 1.21T |
| Operating Cash Flow | 2.24T | 2.36T | 2.37T | 2.26T | 3.01T | 3.01T |
| Investing Cash Flow | -1.35T | -2.00T | -1.99T | -1.74T | -1.70T | -1.42T |
| Financing Cash Flow | 192.45B | -343.03B | -234.45B | -590.20B | -1.44T | -1.69T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $111.39B | 5.74 | 21.92% | 4.42% | 0.20% | 61.54% | |
76 Outperform | $239.20B | 22.34 | 18.18% | 1.75% | 7.30% | 17.67% | |
72 Outperform | $211.47B | 12.35 | 16.86% | 6.60% | 2.42% | 102.17% | |
67 Neutral | $196.09B | 9.18 | 20.43% | 4.56% | 1.98% | 150.68% | |
62 Neutral | $79.45B | 18.23 | 22.81% | 2.69% | 1.14% | 83.48% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
55 Neutral | $83.57B | 11.26 | 10.59% | 2.82% | 2.78% | -8.43% |